These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4156538)

  • 1. A molecular orbital study of tissue selectivity in beta-adrenoceptor blocking agents.
    Germer HA
    J Pharm Pharmacol; 1974 Oct; 26(10):799-806. PubMed ID: 4156538
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic blocking agents. 21. threo-1-(Aryloxy)-3-(alkylamino)butan-2-ols.
    Tucker H
    J Med Chem; 1981 Nov; 24(11):1364-8. PubMed ID: 6118435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling of alpha 2-adrenergic ligands.
    Rouvinen J; Hoffrén AM; Karjalainen A; Pakkanen TA
    Drug Des Discov; 1993; 10(4):285-95. PubMed ID: 7908541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular orbital studies on the mechanism of drug-receptor interaction. 1. Adrenergic drugs. Conformation and reactivity of isoproterenol and 1-(p-nitrophenyl)-2-isopropylaminoethanol.
    Petrongolo C; Tomasi J
    J Med Chem; 1974 May; 17(5):501-7. PubMed ID: 4151491
    [No Abstract]   [Full Text] [Related]  

  • 5. Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.
    Clifton JE; Collins I; Hallett P; Hartley D; Lunts LH; Wicks PD
    J Med Chem; 1982 Jun; 25(6):670-9. PubMed ID: 6124636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-basicity and structure-affinity relationships of beta-adrenergic blocking agents.
    Fernández B; Kaumann AJ
    Acta Physiol Lat Am; 1975; 25(1):45-51. PubMed ID: 3943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of drug absorption with molecular charge distribution.
    Fu XC; Liang WQ; Yu QS
    Pharmazie; 2001 Mar; 56(3):267-8. PubMed ID: 11265598
    [No Abstract]   [Full Text] [Related]  

  • 9. The surface activity and self-association of some beta-adrenoceptor blocking agents in aqueous solution.
    Attwood D; Agarwal SP
    J Pharm Pharmacol; 1979 Jun; 31(6):392-5. PubMed ID: 39139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular orbital calculations for the structure of the muscarine-pharmacophore].
    Höltje HD
    Arch Pharm (Weinheim); 1974 Dec; 307(12):969-72. PubMed ID: 4451455
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-adrenergic drugs: analysis of crystallographic and theoretical results.
    Leger JM; Gadret M; Carpy A
    Mol Pharmacol; 1980 May; 17(3):339-43. PubMed ID: 6104783
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-adrenergic blocking drugs.
    Gerber JG; Nies AS
    Annu Rev Med; 1985; 36():145-64. PubMed ID: 2581498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the counter-ion in molecular orbital calculations of histamine conformations.
    Abraham RJ; Birch D
    Mol Pharmacol; 1975 Sep; 11(5):663-6. PubMed ID: 1177872
    [No Abstract]   [Full Text] [Related]  

  • 14. High-performance liquid chromatographic determination of the enantiomers of beta-adrenoceptor blocking agents in biological fluids. II. Studies with atenolol.
    Chin SK; Hui AC; Giacomini KM
    J Chromatogr; 1989 Apr; 489(2):438-45. PubMed ID: 2568994
    [No Abstract]   [Full Text] [Related]  

  • 15. 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity.
    Franke A; Frickel FF; Gries J; Lenke D; Schlecker R; Thieme PD
    J Med Chem; 1981 Dec; 24(12):1460-4. PubMed ID: 6118439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-short-acting beta-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent.
    Erhardt PW; Woo CM; Gorczynski RJ; Anderson WG
    J Med Chem; 1982 Dec; 25(12):1402-7. PubMed ID: 6130153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-imino tautomerism in the antibiotic formycin A as studied by CNDO-2 molecular orbital theory.
    Ceasar GP; Greene JJ
    J Med Chem; 1974 Oct; 17(10):1122-4. PubMed ID: 4422657
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular orbital calculations on the structure of the barbiturate receptor (author's transl)].
    Höltje HD
    Arch Pharm (Weinheim); 1977 Aug; 310(8):650-62. PubMed ID: 921501
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.
    Hong CY; Turner P
    Br J Clin Pharmacol; 1982 Aug; 14(2):269-72. PubMed ID: 6125206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonidine base: evidence for conjugation of both ring systems.
    Meerman-van Benthem CM; Van der Meer K; Mulder JJ; Timmermans PB; Van Zwieten PA
    Mol Pharmacol; 1975 Sep; 11(5):667-70. PubMed ID: 1177873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.